Paraneoplastic Syndromes

Ugonma Chukwueke, Steven Vernino

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Paraneoplastic neurological syndromes represent indirect complications of certain malignancies, often due to neurological autoimmunity. These are rare, but important, entities, affecting less than 0.1% of patients with cancer. Clinical manifestations can be quite varied and multifocal. Several distinct clinical syndromes are recognized, including sensory neuronopathy, cerebellar degeneration, limbic encephalitis, and Lambert-Eaton syndrome. These disorders are usually associated with a subacute onset and significant disability. Typically, the neurological presentation antedates the diagnosis of malignancy, and the cancer, when found, tends to be localized and responsive to treatment. Diagnosis depends on clinical suspicion, serology for paraneoplastic antibodies, and a focused search for cancer. Imaging studies are important in the diagnosis of central nervous system disorders and also for the detection of occult malignancy. Management of these disorders includes treatment of the cancer (if identified) as well immunotherapy.

Original languageEnglish (US)
Title of host publicationHandbook of Neuro-Oncology Neuroimaging: Second Edition
PublisherElsevier Inc.
Pages103-109
Number of pages7
ISBN (Electronic)9780128011683
ISBN (Print)9780128009451
DOIs
StatePublished - Apr 12 2016

Fingerprint

Paraneoplastic Syndromes
Neoplasms
Limbic Encephalitis
Lambert-Eaton Myasthenic Syndrome
Central Nervous System Diseases
Serology
Autoimmunity
Immunotherapy
Antibodies
Therapeutics

Keywords

  • Autoimmunity
  • Cancer
  • Disorder
  • Malignancy
  • Neurologic
  • Paraneoplastic
  • Syndrome
  • Tumor

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Chukwueke, U., & Vernino, S. (2016). Paraneoplastic Syndromes. In Handbook of Neuro-Oncology Neuroimaging: Second Edition (pp. 103-109). Elsevier Inc.. https://doi.org/10.1016/B978-0-12-800945-1.00013-6

Paraneoplastic Syndromes. / Chukwueke, Ugonma; Vernino, Steven.

Handbook of Neuro-Oncology Neuroimaging: Second Edition. Elsevier Inc., 2016. p. 103-109.

Research output: Chapter in Book/Report/Conference proceedingChapter

Chukwueke, U & Vernino, S 2016, Paraneoplastic Syndromes. in Handbook of Neuro-Oncology Neuroimaging: Second Edition. Elsevier Inc., pp. 103-109. https://doi.org/10.1016/B978-0-12-800945-1.00013-6
Chukwueke U, Vernino S. Paraneoplastic Syndromes. In Handbook of Neuro-Oncology Neuroimaging: Second Edition. Elsevier Inc. 2016. p. 103-109 https://doi.org/10.1016/B978-0-12-800945-1.00013-6
Chukwueke, Ugonma ; Vernino, Steven. / Paraneoplastic Syndromes. Handbook of Neuro-Oncology Neuroimaging: Second Edition. Elsevier Inc., 2016. pp. 103-109
@inbook{35633c77f92b4f77ac2d3b0f15c91704,
title = "Paraneoplastic Syndromes",
abstract = "Paraneoplastic neurological syndromes represent indirect complications of certain malignancies, often due to neurological autoimmunity. These are rare, but important, entities, affecting less than 0.1{\%} of patients with cancer. Clinical manifestations can be quite varied and multifocal. Several distinct clinical syndromes are recognized, including sensory neuronopathy, cerebellar degeneration, limbic encephalitis, and Lambert-Eaton syndrome. These disorders are usually associated with a subacute onset and significant disability. Typically, the neurological presentation antedates the diagnosis of malignancy, and the cancer, when found, tends to be localized and responsive to treatment. Diagnosis depends on clinical suspicion, serology for paraneoplastic antibodies, and a focused search for cancer. Imaging studies are important in the diagnosis of central nervous system disorders and also for the detection of occult malignancy. Management of these disorders includes treatment of the cancer (if identified) as well immunotherapy.",
keywords = "Autoimmunity, Cancer, Disorder, Malignancy, Neurologic, Paraneoplastic, Syndrome, Tumor",
author = "Ugonma Chukwueke and Steven Vernino",
year = "2016",
month = "4",
day = "12",
doi = "10.1016/B978-0-12-800945-1.00013-6",
language = "English (US)",
isbn = "9780128009451",
pages = "103--109",
booktitle = "Handbook of Neuro-Oncology Neuroimaging: Second Edition",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Paraneoplastic Syndromes

AU - Chukwueke, Ugonma

AU - Vernino, Steven

PY - 2016/4/12

Y1 - 2016/4/12

N2 - Paraneoplastic neurological syndromes represent indirect complications of certain malignancies, often due to neurological autoimmunity. These are rare, but important, entities, affecting less than 0.1% of patients with cancer. Clinical manifestations can be quite varied and multifocal. Several distinct clinical syndromes are recognized, including sensory neuronopathy, cerebellar degeneration, limbic encephalitis, and Lambert-Eaton syndrome. These disorders are usually associated with a subacute onset and significant disability. Typically, the neurological presentation antedates the diagnosis of malignancy, and the cancer, when found, tends to be localized and responsive to treatment. Diagnosis depends on clinical suspicion, serology for paraneoplastic antibodies, and a focused search for cancer. Imaging studies are important in the diagnosis of central nervous system disorders and also for the detection of occult malignancy. Management of these disorders includes treatment of the cancer (if identified) as well immunotherapy.

AB - Paraneoplastic neurological syndromes represent indirect complications of certain malignancies, often due to neurological autoimmunity. These are rare, but important, entities, affecting less than 0.1% of patients with cancer. Clinical manifestations can be quite varied and multifocal. Several distinct clinical syndromes are recognized, including sensory neuronopathy, cerebellar degeneration, limbic encephalitis, and Lambert-Eaton syndrome. These disorders are usually associated with a subacute onset and significant disability. Typically, the neurological presentation antedates the diagnosis of malignancy, and the cancer, when found, tends to be localized and responsive to treatment. Diagnosis depends on clinical suspicion, serology for paraneoplastic antibodies, and a focused search for cancer. Imaging studies are important in the diagnosis of central nervous system disorders and also for the detection of occult malignancy. Management of these disorders includes treatment of the cancer (if identified) as well immunotherapy.

KW - Autoimmunity

KW - Cancer

KW - Disorder

KW - Malignancy

KW - Neurologic

KW - Paraneoplastic

KW - Syndrome

KW - Tumor

UR - http://www.scopus.com/inward/record.url?scp=84978336500&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84978336500&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-800945-1.00013-6

DO - 10.1016/B978-0-12-800945-1.00013-6

M3 - Chapter

AN - SCOPUS:84978336500

SN - 9780128009451

SP - 103

EP - 109

BT - Handbook of Neuro-Oncology Neuroimaging: Second Edition

PB - Elsevier Inc.

ER -